Skip to main content
HCWB
NASDAQ Life Sciences

HCW Biologics' Alopecia Drug HCW9302 Shows Positive Phase 1 Results, All Patients Respond in Key Cohort

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.499
Mkt Cap
$8.737M
52W Low
$0.25
52W High
$7.35
52W Position info
500% above low
Off High info
80% below high
Rel. Volume
Market data snapshot near publication time

HCWB has more than doubled off its 52-week low of $0.25.

Summary

HCW Biologics announced positive preliminary Phase 1 results for its IL-2 based immunotherapeutic, HCW9302, in alopecia areata. All three participants in the second dose cohort (3 micrograms/kg) showed a >=25% reduction in SALT scores, indicating clinical improvement. The drug was well-tolerated with no dose-limiting toxicities or serious IL-2 related adverse effects. This positive clinical development provides a crucial boost for the company, which has recently faced a going concern warning, Nasdaq delisting threat, and has been actively raising capital and seeking a reverse stock split. The company aims to establish the Recommended Phase 2 Dose by year-end 2026.

At the time of this announcement, HCWB was trading at $1.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.7M. The 52-week trading range was $0.25 to $7.35. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

HCWB - Latest Insights

HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.7701 info
Change: -$0.0099 (-1%) info
Market Cap: $1.722M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.7701 info
Change: -$0.0099 (-1%) info
Market Cap: $1.722M info
HCWB
Nov 16, 2026, 8:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.780
Real-time Price: $0.7701 info
Change: -$0.0099 (-1%) info
Market Cap: $1.722M info
HCWB
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $0.7701 info
Change: -$0.3199 (-29%) info
Market Cap: $1.722M info
HCWB
Nov 05, 2026, 8:45 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $0.7701 info
Change: -$0.3899 (-34%) info
Market Cap: $1.722M info